Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Factor VIII in Patients with Classic Haemophilia

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Studies of Factor VIII pharmacokinetics in haemophiliacs can be classified into 2 groups depending on whether single-dose or multiple-dose Factor VIII curves are used. This review analyses information published so far in both these areas, with particular emphasis on the choice of appropriate models for pharmacokinetic analysis.

Single-dose studies of Factor VIII kinetics have previously used a wide variety of methods for pharmacokinetic analysis (empirical methods of Factor VIII level prediction, graphical techniques for semilog analysis, 1-compartment and 2-compartment models). However, Factor VIII poses unique problems to the pharmacokineticist because decay curves can be either monophasic (monoexponential) or biphasic (biexponential) for unknown reasons, and because Factor VIII concentrations are generally subject to significant assay error. Problems of compartmental analysis that occurred in previous studies are highlighted, and a model-independent non-compartmental approach for analysing Factor VIII curves is proposed.

To date, fewer data have been published on multiple-dose kinetics of Factor VIII. From a clinical point of view, repeated-dose regimens are most commonly required in patients undergoing surgery and in patients with severe bleeding. A fairly well defined ‘therapeutic window’ of optimal Factor VIII plasma concentrations has been identified, particularly in surgical patients. This fact has spurred research aimed at applying to haemophilia patients the pharmacokinetic dosing methods commonly used for therapeutic monitoring of drugs (e.g. Bayesian method for dosage individualisation). A few papers have already been published in this field, and this review summarises problems encountered by previous investigators, and evaluates comparatively the pharmacokinetic methods used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abilgaard CF, Cornet JA, Fort E, Schulman I. The in vivo longevity of antihaemophilic factor (Factor VIII). British Journal of Haematology 10: 225–231, 1963

    Article  Google Scholar 

  • Aledort LM, Levine PH. Surgery in hemophilia, Series on the treatment of hemophilia, World Federation of Hemophilia, Berkeley, 1977

    Google Scholar 

  • Allain JP. Principles of in vivo recovery and survival studies. Scandinavian Journal of Haematology 33 (Suppl. 40): 161–163, 1984a

    Google Scholar 

  • Allain JP. Principles of in vivo recovery and survival studies. Scandinavian Journal of Haematology 33 (Suppl. 41): 123–130, 1984b

    Google Scholar 

  • Austen DEG, Rhymes IR, Rizza CR. Factor VIII concentrates: what the label says. Lancet 2: 1167, 1981

    Article  PubMed  CAS  Google Scholar 

  • Barrowcliffe TW, Thomas DP. Factor VIII standardisation. Lancet 2: 1342, 1981

    Article  PubMed  CAS  Google Scholar 

  • Beal SL, Sheiner LB. NONMEM users guide, parts I and II. Technical report, Division of Clinical Pharmacology, University of California, San Francisco, 1980

    Google Scholar 

  • Boxenbaum HG, Riegelman S, Elashoff RM. Statistical estimation in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 2: 123–145, 1974

    PubMed  CAS  Google Scholar 

  • Brownlee GG, Rizza C. Clotting Factor VIII cloned. Nature 312: 307, 1984

    Article  PubMed  CAS  Google Scholar 

  • Burton ME, Brater DC, Chen PS, Day RB, Huber PJ, et al. A Bayesian feedback method of aminoglycoside dosing. Clinical Pharmacology and Therapeutics 37: 349–357, 1985

    Article  PubMed  CAS  Google Scholar 

  • Duncan B, Lloyd J, Lesnikowski E. Successive Factor VIII doses for a haemophiliac undergoing major surgery calculated on a microcomputer. Thrombosis and Haemostasis 47: 66–68, 1982

    PubMed  CAS  Google Scholar 

  • Eyster ME, Ladda RL, Bowman HS. Carrier with excessively low Factor VIII procoagulant activity (VIII AHF): a study of two unrelated families with mild hemophilia A. Blood 49: 607–618, 1977

    PubMed  CAS  Google Scholar 

  • Gibaldi M, Perrier D. Pharmacokinetics, Marcel Dekker, New York, 1982

    Google Scholar 

  • Hermens WT. Calculation of human Factor VIII and Factor IX concentrates for infusion therapy. In Brinkhous & Hemker (Eds) Handbook of hemophilia, pp. 569–589, Elsevier, New York, 1975

    Google Scholar 

  • Holmberg L, Borge L, Nilsson IM. Factor VIII:C and VIII:C Ag response in patients with haemophilia A and von Willebrand’s disease after administration of different Factor VIII concentrates or plasma. British Journal of Haematology 47: 587–596, 1981

    Article  PubMed  CAS  Google Scholar 

  • Ingram GI. Calculating the dose Factor VIII in the management of haemophilia. British Journal of Haematology 48: 351–354, 1981

    PubMed  CAS  Google Scholar 

  • Johnson AJ, Karpatkin MH, and Newman J. Clinical investigation of intermediate and high-purity antihaemophilic factor (Factor VIII) concentrates. British Journal of Haematology 21: 21–27, 1971

    Article  PubMed  CAS  Google Scholar 

  • Kasper CK, Boylen L, Ewing NP. Hematologic management of hemophilia A for surgery. Journal of the American Medical Association 253: 1279–1283, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kasper CK. In vivo recovery of FVIII:C in hemophilic patients. Scandinavian Journal of Haematology 33: 147–154, 1984

    Article  Google Scholar 

  • Kitchens CS. Surgery in hemophilia and related disorders: a prospective study of 100 consecutive procedures. Medicine 65: 34–45, 1986

    Article  PubMed  CAS  Google Scholar 

  • Kjellman H. Calculations of Factor VIII in vivo recovery and half-life. Scandinavian Journal of Haematology 33 (Suppl. 40): 165–174, 1984

    Google Scholar 

  • Kopitsky RG, Geltman EM. Unstable angina associated with Factor VIII concentrate therapy for hemophilia A. Annals of Internal Medicine 105: 215–216, 1986

    PubMed  CAS  Google Scholar 

  • Longo G, Matucci M, Messori A, Morfini M, Rossi-Ferrini P. Pharmacokinetic of a new heat-treated concentrate of Factor VIII estimated by model-independent methods. Thrombosis Research 42: 471–476, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Longo G, Matucci M, Messori A, Morfini M, Rossi-Ferrini P. Pharmacokinetics of factor VIII in hemophilia patients undergoing major surgery. Ricerca in Clinica e Laboratorio 16: 208, 1986b

    Google Scholar 

  • Longo G, Matucci M, Morfini M, Vannini S, Messori A. A calculator program for individualizing Factor VIII dosage. Drug Intelligence and Clinical Pharmacy 18: 726–730, 1984

    PubMed  CAS  Google Scholar 

  • Lusher JM. Factor VIII concentrates: matching what you see with what you get. Journal of the American Medical Association 254: 802–803, 1985

    Article  PubMed  CAS  Google Scholar 

  • Matucci M, Messori A, Donati-Cori G, Longo G, Vannini S, et al. Kinetic evaluation of four Factor VIII concentrates by model independent methods. Scandinavian Journal of Haematology 34: 22–28, 1985

    Article  PubMed  CAS  Google Scholar 

  • McLellan DS, Pelly C, McLellan HG, Aronstam A. The in-vivo survival characteristics of Factor VIII procoagulant antigen (VIII: CAg) in haemophilia A subjects. Thrombosis Research 25: 33–39, 1982

    Article  PubMed  CAS  Google Scholar 

  • Messori A, Donati-Cori G, Tendi E. Iterative least-squares fitting programs in pharmacokinetics for a programmable hand-held calculator. American Journal of Hospital Pharmacy 40: 1673–1684, 1983

    PubMed  CAS  Google Scholar 

  • Messori A, Longo G, Matucci M, et al. A pharmacokinetic model for analyzing Factor VIII plasma levels in hemophilia patients undergoing major surgery. In Lindgren et al. (Eds) Progress in clinical pharmacy pp. 185–192, Swedish Pharmaceutical Press, Stockholm, 1986a

    Google Scholar 

  • Messori A, Longo G, Matucci M, Morfini M, Rossi-Ferrini P. A package of microcomputer programs for analyzing the pharmacokinetics of factor VIII in patients with classic hemophilia. Ricerca in Clinica e Laboratorio 16: 157, 1986b

    Google Scholar 

  • Messori A, Longo G, Morfini M, Donati-Cori G, Matucci M, et al. Individualization of Factor VIII dosage. Journal of Clinical and Hospital Pharmacy 9: 95–103, 1984a

    PubMed  CAS  Google Scholar 

  • Messori A, Morfini M, Longo G, Matucci M. Single-dose pharmacokinetics of Factor VIII. Thrombosis Research 41: I, 1986c

    Google Scholar 

  • Messori A, Rosselli P. A calculator program for estimating modelindependent pharmacokinetic parameters. Bollettino Chimico Farmaceutico 123: 530–538, 1984b

    PubMed  CAS  Google Scholar 

  • Mikaelsson M, Nilsson IM, Cedergen B. The use of desmopressin (DDAVP) in the preparation of improved Factor VIII concentrate. Scandinavian Journal of Haematology 33 (Suppl. 40): 93–102, 1984

    Google Scholar 

  • Morfini M, Cinotti S, Longo G, Matucci M, Messori A, et al. Pharmacokinetics of a new steam-treated Factor VIII concentrate estimated by compartmental and non-compartmental methods. Proceedings of the Göteborg Symposium, Sweden, in press, 1986c

  • Morfini M, Grasela TH, Longo G, Matucci M, Messori A, et al. Comparison of two pharmacokinetic techniques for individualizing Factor VIII dosage in haemophilia patients. Haematologica 70: 454–456, 1985a

    PubMed  CAS  Google Scholar 

  • Morfini M, Longo G, Matucci M, Messori A, Rossi-Ferrini P. Single-dose pharmacokinetics of three heat-treated concentrates of factor VIII. Ricerca in Clinica e Laboratorio 16: 215, 1986a

    Google Scholar 

  • Morfini M, Longo G, Matucci M, Vannini S, Messori A, et al. Cryoprecipitate and Factor VIII commercial concentrates. Ricerca in Clinica e Laboratorio 9: 95–103, 1984

    Google Scholar 

  • Morfini M, Messori A, Longo G, Cinotti S, Matucci M, et al. Half-life and in vivo recovery of heated factor VIII concentrates. Lancet 2: 571–572, 1986b

    Article  PubMed  CAS  Google Scholar 

  • Morfini M, Messori A, Longo G, Matucci M, Rossi-Ferrini P. Pharmacokinetics of three heat-treated concentrates of Factor VIII. In Ciavarella et al. (Eds) Factor VIII von Willebrand factor: biological and clinical advances, pp. 303–307, Wichtig, Milan, 1985b

    Google Scholar 

  • Morfini M, Rafanelli D, Longo G, Messori A, Rossi Ferrini P. Hepatitis-free interval after clotting factor therapy in first infused haemophiliacs. Thrombosis and Haemostasis 56: 268–270, 1986d

    PubMed  CAS  Google Scholar 

  • Nilsson IM, Blomback M, Ramgren D. Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I-O). Acta Medica Scandinavica 379: 61–66, 1962

    PubMed  CAS  Google Scholar 

  • Nilsson IM, Hedner U. Characteristics of various Factor VIII concentrates used in treatment of hemophilia A. British Journal of Haematology 37: 543–557, 1977

    Article  PubMed  CAS  Google Scholar 

  • Nilsson IM, Walter H, Mikaelsson M, Vilhardt G. Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma. Scandinavian Journal of Haematology 22: 42–46, 1979

    Article  PubMed  CAS  Google Scholar 

  • Noe D, Bell WR, Ness PM, Levin J. Plasma clearance rates of coagulation Factors VIII and IX in factor-deficient individuals. Blood 67: 969–972, 1986

    PubMed  CAS  Google Scholar 

  • Over J, Sixma JJ, Doucet DeBruine MH, et al. Survival of 125-Iodine-labeled Factor VIII in normals and patients with classic haemophilia. Journal of Clinical Investigations 62: 223–224, 1978

    Article  CAS  Google Scholar 

  • Over J, Triescnigg AM, Vlooswijk HA, et al. Survival of radiolabelled human Factor VIII in vivo. British Journal of Haematology 35: 680–687, 1977

    Google Scholar 

  • Pavlovsky A, Pavlovsky AA, de Tezanos PM, Canaveri AM, Funes JC. Turnover of factor VIII. Thrombosis et Diathesis Haemorrhagica 13: 209–213, 1964

    Google Scholar 

  • Ratnoff OD. Factor VIII concentrates. Journal of the American Medical Association 255: 325–326, 1986

    Article  PubMed  CAS  Google Scholar 

  • Rock G, Smiley RK, Tittley P, Palmer DS. In vivo effectiveness of a high-yield Factor VIII concentrate prepared in a blood bank. New England Journal of Medicine 11: 310–313, 1984

    Article  Google Scholar 

  • Rock G, Tittley P, Fuller V. An in vivo assessment of Factor VIII concentrates. Journal of the American Medical Association 254: 777–780, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rosen S, Oswaldsson U, Blombäck M, Larrieu M, Nilsson IM, et al. A collaborative comparison of a chromogenic Factor VIII:C method with one- and two-stage clotting methods. Thrombosis and Haemostasis 50: 112, 1983

    Google Scholar 

  • Ruffo S, Matucci M, Longo G, Morfini M, Vannini S, et al. A weighted least-squares approach for fitting to kinetic models the plasma concentration data of phenytoin and Factor VIII. Farmaco. Edizione Pratica 39: 211–221, 1984

    CAS  Google Scholar 

  • Ruffo S, Messori A, Donati-Cori G, Tendi E, Rosselli P, et al. Calculator programs for weighted least-squares iterative fits in pharmacokinetics. American Journal of Hospital Pharmacy 42: 628–630, 1985a

    PubMed  CAS  Google Scholar 

  • Ruffo S, Messori A, Grasela TH, Longo G, Donati-Cori G, et al. A calculator program for clinical application of the Bayesian method of predicting plasma drug levels. Computer Programs in Biomedicine 19: 167–177, 1985b

    Article  PubMed  CAS  Google Scholar 

  • Ruffo S, Messori A, Longo G, Matucci M, Morfini M, et al. A microcomputer program for individualizing Factor VIII dosage in hemophilia patients undergoing major surgery. Computer Programs in Biomedicine 23: 37–46, 1986

    Article  CAS  Google Scholar 

  • Sampson JF, Hamstra R, Aldrete JA. Surgical management of patients with hemophilia. Anaesthesiology Annals 58: 133–138, 1979

    CAS  Google Scholar 

  • Sawchuk RJ, Zaske DE, Cipolle RJ, Wargin WA, Strate RG. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clinical Pharmacology and Therapeutics 21: 362–369, 1977

    PubMed  CAS  Google Scholar 

  • Schimpf K, Rothmann P, Schumacher K. Comparison of Factor VIII concentrates in non-bleeding patients. Scandinavian Journal of Haematology 33 (Suppl. 41): 131–145, 1984

    Google Scholar 

  • Sheiner LB. ELSFIT — Users Manual, Division of Clinical Pharmacology, University of California, San Francisco, 1983

    Google Scholar 

  • Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics 11: 303–319, 1983

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics 26: 294–305, 1979

    PubMed  CAS  Google Scholar 

  • Smit Sibinga CT, Daenen SM, van Imhoff GW, Maas A, Das PC. Heparin small pool high yield purified Factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate. Thrombosis and Haemostasis 51: 12–15, 1984a

    PubMed  CAS  Google Scholar 

  • Smit Sibinga CT, Das PC. Heparin and Factor VIII. Scandinavian Journal of Haematology 33 (Suppl. 40): 111–122, 1984b

    Google Scholar 

  • Thomson AH, Kelman AW, De Vane PJ, et al. Fitting concentration-time data: a weighting dilemma? In Lindgren et al. (Eds) Progress in clinical pharmacy, pp. 177–188, Swedish Pharmaceutical Press, Stockholm, 1986

    Google Scholar 

  • Thorell L, Blomback M, Blomback B. An in vivo study of a new Factor VIII high purity preparation. Thrombosis and Haemostasis 31: 375–385, 1983

    CAS  Google Scholar 

  • Thorell L, Blomback B. Purification of the Factor VIII complex. Thrombosis Research 35: 431–450, 1984

    Article  PubMed  CAS  Google Scholar 

  • Toolis F, McKay G, Prowse CV. In vivo characteristics of thaw siphon cryoprecipitate compared to other Factor VIII preparations. Thrombosis and Haemostasis 43: 25–30, 1980

    PubMed  CAS  Google Scholar 

  • Tuddenham EG, Lane RS, Rotblat FJ, Snape TJ. Response to infusions of polyelectrolyte fractionated human Factor VIII concentrate in human haemophilia-A and von Willebrand disease. British Journal of Haematology 52: 259–267, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wagner JG, Metzler CM. Estimation of rate constants for absorption and elimination from blood concentration data. Journal of Pharmaceutical Sciences 56: 658–662, 1967

    Article  PubMed  CAS  Google Scholar 

  • Williams WJ. Life span of plasma coagulation factors. In Williams (Ed.) Hematology, pp. 1230–1237, McGraw Hill, New York, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haemophilia Center, USL 10/D and University of Florence, Ospedale di Careggi, Viale Morgagni 85, 50134, Florence, Italy

    Andrea Messori, Giovanni Longo, Marzia Matucci,  Massimo Morfini & Pier Luigi Rossi Ferrini

Authors
  1. Andrea Messori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Longo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marzia Matucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Morfini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pier Luigi Rossi Ferrini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Messori, A., Longo, G., Matucci, M. et al. Clinical Pharmacokinetics of Factor VIII in Patients with Classic Haemophilia. Clin-Pharmacokinet 13, 365–380 (1987). https://doi.org/10.2165/00003088-198713060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198713060-00002

Keywords

Search

Navigation